Barely Significant
← all excerpts

Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective.

Viruses · 2021 · PMC7998902 · PMID 33807839

Europe PMCDOI
1
hedged sentence
0.0700
closest p · 1.4× alpha
0.0700
boldest claim

The sentences

nearly significantp = 0.07so close (0.05 < p ≤ 0.1)
A calculation based on early data shows a nearly significant correlation between vaccine efficacy versus post-vaccination neutralization log-titer (r 2 = 0.39, p = 0.07, see Supplementary Materials Table S3, Figure S1 ).

also in 3,279 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.